Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
354.5 USD | -0.01% | +0.59% | +18.37% |
25.04. | Cigna bietet Humira-Rivalen mit $0 Zuzahlung in Spezialapotheke an | RE |
24.04. | The Cigna Group beschließt Quartalsdividende, zahlbar am 20. Juni 2024 | CI |
ETFs investiert in Cigna
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
2,33% | 8 M€ | +2.44% | ||
2,28% | 18 M€ | +3.79% | - | |
1,93% | 2 M€ | +6.77% | ||
1,81% | 1 M€ | +2.21% | - | |
1,09% | 204 M€ | +10.54% | ||
1,05% | 9 M€ | -.--% | - | |
0,95% | 5 M€ | -72.95% | - | |
0,92% | 1 M€ | +16.32% | ||
0,88% | 3 M€ | +15.16% | - | |
0,88% | 4 M€ | -.--% | - | |
0,88% | 13 M€ | -.--% | - | |
0,70% | 10 M€ | +5.96% | ||
0,68% | 4 592 M€ | +11.18% | ||
0,61% | 3 859 M€ | +18.82% | - | |
0,61% | 469 M€ | -2.05% | - | |
0,61% | 717 M€ | +6.20% | ||
0,55% | 8 M€ | +3.30% | - | |
0,48% | 52 M€ | +6.98% | ||
0,48% | 5 M€ | -.--% | - | |
0,46% | 219 M€ | +17.17% | - | |
0,46% | 1 448 M€ | -.--% | - | |
0,44% | 26 M€ | +2.00% | - | |
0,43% | 330 M€ | -.--% | - | |
0,40% | 2 M€ | +14.69% | - | |
0,40% | 2 510 M€ | +12.00% |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+18.37% | 101 Mrd. | |
-5.91% | 456 Mrd. | |
+13.93% | 125 Mrd. | |
-0.28% | 39.69 Mrd. | |
-33.18% | 36.86 Mrd. | |
-5.28% | 20.05 Mrd. | |
-13.82% | 3.08 Mrd. | |
-39.49% | 993 Mio. | |
-28.58% | 337 Mio. |
- Börse
- Aktien
- A2PA9L Aktie
- ETFs Cigna